These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37698033)

  • 1. Baseline gut microbiome features prior to SARS-CoV-2 infection are associated with host symptoms in and post COVID-19.
    Zuo T; Liang G; Huang Z; Cao Z; Bai F; Zhou Y; Wu X; Wu X; Chen YQ; Balati M; Maimaitiyiming M; ; Lan P
    J Med Virol; 2023 Sep; 95(9):e29083. PubMed ID: 37698033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 alters human microbiomes: a meta-analysis.
    Reuben RC; Beugnon R; Jurburg SD
    Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.
    Zuo T; Liu Q; Zhang F; Yeoh YK; Wan Y; Zhan H; Lui GCY; Chen Z; Li AYL; Cheung CP; Chen N; Lv W; Ng RWY; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Microbiome; 2021 Apr; 9(1):91. PubMed ID: 33853691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
    Cyprian F; Sohail MU; Abdelhafez I; Salman S; Attique Z; Kamareddine L; Al-Asmakh M
    Int J Infect Dis; 2021 Apr; 105():540-550. PubMed ID: 33610778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
    Galperine T; Choi Y; Pagani JL; Kritikos A; Papadimitriou-Olivgeris M; Méan M; Scherz V; Opota O; Greub G; Guery B; Bertelli C;
    BMC Infect Dis; 2023 Aug; 23(1):537. PubMed ID: 37596518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
    Wang M; Zhang Y; Li C; Chang W; Zhang L
    Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
    Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
    Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
    Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
    Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms.
    Mendes de Almeida V; Engel DF; Ricci MF; Cruz CS; Lopes ÍS; Alves DA; d' Auriol M; Magalhães J; Machado EC; Rocha VM; Carvalho TG; Lacerda LSB; Pimenta JC; Aganetti M; Zuccoli GS; Smith BJ; Carregari VC; da Silva Rosa E; Galvão I; Dantas Cassali G; Garcia CC; Teixeira MM; André LC; Ribeiro FM; Martins FS; Saia RS; Costa VV; Martins-de-Souza D; Hansbro PM; Marques JT; Aguiar ERGR; Vieira AT
    Gut Microbes; 2023 Dec; 15(2):2249146. PubMed ID: 37668317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiome and anti-viral immunity in COVID-19.
    Rossini V; Tolosa-Enguis V; Frances-Cuesta C; Sanz Y
    Crit Rev Food Sci Nutr; 2024; 64(14):4587-4602. PubMed ID: 36382631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota.
    Li S; Zhou Y; Yan D; Wan Y
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity and COVID-19 - The microbiotal connection.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
    Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
    Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosis.
    Seong H; Kim JH; Han YH; Seo HS; Hyun HJ; Yoon JG; Nham E; Noh JY; Cheong HJ; Kim WJ; Lim S; Song JY
    Front Immunol; 2023; 14():1079277. PubMed ID: 37051240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
    Wang Y; Wu G; Zhao L; Wang W
    mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
    Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC
    Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.